Entering text into the input field will update the search result below

AngioDynamics Q4 revenues down 7%; updates FY18 guidance

  • AngioDynamics (NASDAQ:ANGO) Q4 results: Revenues: $86.9M (-7.0%); Operating Loss: ($9.3M); Net Loss: ($10.9M) (+74.7%); Loss Per Share: ($0.30) (+74.8%); Non-GAAP EPS: $0.19 (-5.0%); Quick Assets: $48.8M (+43.5%); CF Ops: $19M (+2.7%).
  • FY2018 Guidance: Revenue: $352M - 359M; Non-GAAP EPS: $0.64 - 0.68; FCF: >$35M.

Recommended For You

More Trending News

About ANGO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ANGO--
AngioDynamics, Inc.